Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.
Back to BlogEye Care

Latanoprost Eye Drops (Xalatan): Side Effects, How to Use, Storage and Cost

S

SafeRxPills Pharmacy Team

Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

July 7, 202626 min read
Last updated: October 29, 2026
Share:
In this article (25 sections)

Latanoprost 0.005% is a once-a-day eye drop that lowers pressure inside the eye in people with open-angle glaucoma or ocular hypertension. It was first approved by the FDA as Xalatan on 5 June 1996, and generic latanoprost has been approved in the US since 2011.

This guide covers what latanoprost is, how to use and store it, the side effects with the actual rates from the US label, the iris and eyelash changes people worry about, who should not use it, how Xalatan, generic latanoprost and the newer preservative-free versions differ, and a short note on cost. We sell two Indian latanoprost brands, so we have a commercial interest; every number below comes from the FDA labels, FDA databases, a published trial and federal price data listed under Sources. Glaucoma needs an eye doctor. Do not start, stop or switch glaucoma drops without one.

The short answer

Latanoprost is a prostaglandin analog. One drop in the affected eye or eyes each evening lowers eye pressure, starting 3 to 4 hours after the drop and peaking at 8 to 12 hours. In the trials behind the US label, people starting with an average pressure of 24 to 25 mmHg dropped by 6 to 8 mmHg over 6 months, the same effect as timolol 0.5% used twice a day.

The most common side effects are eye surface symptoms: foreign body sensation (13%), punctate keratitis (10%), stinging (9%) and red eyes (8%). The two changes that matter most long term are browning of the iris, seen in 7% of patients within 6 months and likely to be permanent, and longer, thicker, darker lashes in the treated eye. Unopened bottles of standard latanoprost go in the fridge; once opened, the US labels allow room temperature up to 25 °C for 6 weeks, while the UK label and the Indian listing for Latoprost say to use it within 4 weeks of opening.

What latanoprost is

Latanoprost is a synthetic analogue of prostaglandin F2-alpha, a natural signalling molecule. The eye drop is a prodrug: the cornea's enzymes convert it into its active acid form as it passes through. Each millilitre of the standard solution contains 50 micrograms of latanoprost (0.005%), and one drop delivers about 1.5 micrograms.

The US label approves it for one purpose: reducing raised intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. The label calls raised pressure a major risk factor for glaucoma damage and says the higher the pressure, the greater the likelihood of optic nerve damage and visual field loss. Latanoprost does not repair damage that has already happened. It slows further loss by keeping pressure down, which is why it is used every day for years.

Latanoprost is one of several glaucoma drug classes. If you want the full picture of beta blockers, alpha agonists, carbonic anhydrase inhibitors and the rest, see our guide to the types of glaucoma eye drops. Our glaucoma page lists the glaucoma drops we stock.

How latanoprost lowers eye pressure

The front of the eye makes a clear fluid, aqueous humor, and drains it continuously. Pressure rises when drainage cannot keep up. The label says latanoprost is believed to lower pressure by increasing the outflow of aqueous humor, mainly through the uveoscleral route, a drainage path that runs through the muscle and tissue around the iris rather than the main drainage channel.

Timing from the label:

  • Pressure starts to fall about 3 to 4 hours after the drop.
  • The maximum effect is reached after 8 to 12 hours.
  • The pressure reduction lasts at least 24 hours, which is why one drop a day is enough.

Very little reaches the rest of the body. The active acid can be measured in the blood only during the first hour after a drop, and it is cleared quickly, with a half-life of 17 minutes. That helps explain why the trial tables are dominated by eye symptoms rather than whole-body effects.

How well latanoprost works: the trial numbers

The US label rests on three multicentre randomized trials that compared latanoprost 0.005% once daily with timolol 0.5% twice daily. Patients with a mean baseline pressure of 24 to 25 mmHg had 6 to 8 mmHg reductions after 6 months, and the label calls the effect equivalent to timolol.

Lower pressure is a surrogate. The study that tested whether latanoprost protects vision against placebo was the UK Glaucoma Treatment Study (UKGTS), published in The Lancet in 2015. It enrolled 516 people with newly diagnosed open-angle glaucoma at ten UK centres, who used either latanoprost or identical placebo drops in both eyes once a day.

UKGTS resultLatanoprost 0.005%Placebo
Patients randomized258258
Baseline mean eye pressure19.6 mmHg20.1 mmHg
Mean pressure reduction at 24 months3.8 mmHg (231 assessed)0.9 mmHg (230 assessed)
Visual field preservationLonger with latanoprost: adjusted hazard ratio 0.44 (95% CI 0.28 to 0.69; p=0.0003)
Serious adverse events18 in total, none attributed to the study drug
Bar chart of mean eye pressure reduction at 24 months in the UKGTS trial: latanoprost 0.005% 3.8 mmHg, placebo 0.9 mmHg. Visual field preservation was longer with latanoprost, adjusted hazard ratio 0.44.
Figure 1. Mean fall in eye pressure after 24 months of latanoprost or placebo drops in the UK Glaucoma Treatment Study, the placebo-controlled trial that also measured visual field loss. Source: Garway-Heath et al. 2015.

A hazard ratio of 0.44 means that, at any point in the 24 months, people on latanoprost had a little under half the rate of visual field deterioration seen with placebo. The authors describe it as the first randomized placebo-controlled trial to show visual field preservation with a pressure-lowering drug in open-angle glaucoma. Note the starting pressure here was about 20 mmHg, lower than in the label trials, so the pressure drop was smaller in absolute terms.

How to use latanoprost eye drops

The label dose is one drop in the affected eye or eyes once daily in the evening. A standard routine:

  1. Wash your hands. If you wear contact lenses, take them out first.
  2. Tilt your head back and pull the lower eyelid down to form a small pocket.
  3. Hold the bottle over the eye and squeeze out one drop into the pocket. Do not let the tip touch your eye, eyelid, fingers or any surface; the label warns that a contaminated tip can carry bacteria that cause eye infections.
  4. Close the eye gently for a moment and wipe away any liquid that runs onto the skin.
  5. Repeat in the other eye only if your doctor prescribed both eyes.
  6. Recap the bottle.

Do not use it more than once a day. The label is direct about this: using prostaglandin drops more than once daily may decrease the pressure-lowering effect or cause paradoxical rises in pressure. The label also says that combining two or more prostaglandins or prostaglandin analogs is not recommended, which matters if you also use a bimatoprost lash serum (more on this below).

If you miss a dose, the label says to continue with the next dose as normal. Do not put in two drops to catch up.

Contact lenses, other eye drops and timing

Standard latanoprost (Xalatan and the US generics) contains benzalkonium chloride (BAK) 0.02% as a preservative. The label says BAK may be absorbed by contact lenses, so lenses should be removed before the drop and may be put back 15 minutes later. The Xelpros and Iyuzeh labels give the same 15-minute rule even though they do not contain BAK.

If you use more than one eye drop, the label says to space them at least 5 minutes apart. As general advice, the gap also keeps a second drop from rinsing the first one out of the eye. Latanoprost is often combined with a second glaucoma drop from another class; ask your doctor which order and times to use. The label also notes that a precipitate forms when eye drops containing thimerosal are mixed with Xalatan in laboratory studies.

How long a bottle lasts

A standard bottle holds 2.5 mL. The label figures allow a rough estimate: 2.5 mL at 50 micrograms per mL is 125 micrograms of latanoprost, and at about 1.5 micrograms per drop that is roughly 83 drops. This is our arithmetic, not a label figure. The UK summary of product characteristics for a generic latanoprost 2.5 mL bottle (Zentiva) gives a similar number, approximately 80 drops. Real drop size varies with the bottle and how you squeeze it.

UseDrops in 4 weeksDrops in 6 weeksRoughly enough from one 2.5 mL bottle (about 80 drops)?
One eye, once nightly2842Yes in both cases, with drops to spare
Both eyes, once nightly5684Yes for 4 weeks; for 6 weeks, about one drop short, with no allowance for missed or wasted drops

The time limit after opening depends on the product. The 6 weeks at room temperature is the US label rule for Xalatan and US generic latanoprost. The UK summary of product characteristics for a generic latanoprost bottle (emc 5974) gives 4 weeks after first opening, and the Tata 1mg listing for Latoprost (Sun Pharma), one of the brands we sell, says to use it within 4 weeks of opening. Follow the carton of the bottle you have: if it says 4 weeks, discard the bottle at 4 weeks even if liquid remains.

Storage: refrigerate before opening

Standard latanoprost should be refrigerated before the bottle is opened. The Xalatan label and the generic labels we checked (Sandoz and Lifestar) give the same rules:

ProductBefore openingAfter opening
Xalatan and US generic latanoprost solution (with BAK)Refrigerate at 2 to 8 °C (36 to 46 °F), protect from light. During shipment to the patient, up to 40 °C (104 °F) for no more than 8 days.Room temperature up to 25 °C (77 °F) for 6 weeks
Xelpros emulsion (potassium sorbate)2 to 25 °C (36 to 77 °F), protect from light. Up to 40 °C for no more than 8 days in shipment.Use until the expiry date on the bottle
Iyuzeh single-dose units (no preservative)15 to 25 °C (59 to 77 °F) in the original foil pouchOpened pouch: up to 30 days at 15 to 25 °C. Each unit is used once and thrown away.

Practical points: keep unopened spare bottles in the fridge at 2 to 8 °C. Write the opening date on the bottle. Do not leave an open bottle in a hot car or on a sunny windowsill. If your bottle is a brand made outside the US, follow the storage instructions printed on its own carton, which may differ from the US labels. For example, the UK label and the Indian listing for Latoprost give 4 weeks after opening rather than 6.

Latanoprost side effects: the label rates

The clearest side effect data come from the three controlled trials in the Xalatan label: 460 patients on latanoprost once daily and 369 on timolol twice daily, mean age 65, followed for 6 months. Seven percent of patients withdrew before the 6-month endpoint. The generic latanoprost labels repeat the same tables.

Reported by 5% to 15% of latanoprost patientsLatanoprost (n=460)Timolol (n=369)
Foreign body sensation13%8%
Punctate keratitis (tiny spots of surface damage on the cornea)10%9%
Stinging9%12%
Conjunctival hyperemia (red eye)8%3%
Blurred vision8%8%
Itching8%8%
Burning7%8%
Increased pigmentation of the iris7%0%
Grouped bar chart of ocular reactions, latanoprost versus timolol: foreign body sensation 13% vs 8%, punctate keratitis 10% vs 9%, stinging 9% vs 12%, conjunctival hyperemia 8% vs 3%, blurred vision 8% vs 8%, itching 8% vs 8%, burning 7% vs 8%, increased iris pigmentation 7% vs 0%.
Figure 2. Eye reactions reported by 5% to 15% of latanoprost patients in the three controlled trials behind the US label, next to the timolol comparison group. Source: Xalatan US label, Table 1.

Most of these symptoms happened at similar rates with timolol. The two that stand out for latanoprost are red eyes (8% vs 3%) and iris darkening (7% vs 0%). Less than 1% of patients stopped treatment because they could not tolerate the redness.

Reactions reported by 1% to 5% of latanoprost patients:

ReactionLatanoprostTimolol
Excessive tearing4%6%
Eyelid discomfort or pain4%2%
Dry eye3%3%
Eye pain3%3%
Eyelid margin crusting3%3%
Redness of the eyelid3%2%
Light sensitivity2%1%
Eyelid swelling1%3%
Blepharitis1%3%
Upper respiratory infection, cold or flu3%3%
Muscle, joint or back pain1%0.5%
Rash or allergic skin reaction1%0.3%

Less common side effects reported after approval

The label also lists reactions reported voluntarily after approval. Their frequency cannot be estimated, and a cause is not always established, but they are on the label because of seriousness, frequency of reports or a possible link:

  • Eye: keratitis, corneal swelling and erosions, intraocular inflammation (iritis or uveitis), macular edema including cystoid macular edema, ingrowing lashes (trichiasis), deepening of the eyelid sulcus (the eye looking more sunken), iris cyst, eyelid skin darkening, conjunctivitis, and pseudopemphigoid of the conjunctiva.
  • Breathing: asthma and worsening of asthma, shortness of breath.
  • Heart: angina, unstable angina, palpitations, chest pain.
  • Other: dizziness, headache, nausea, vomiting, itching, herpes keratitis, and toxic epidermal necrolysis (a severe skin reaction).

Get urgent medical help for chest pain, trouble breathing, a blistering or peeling rash, a sudden painful red eye or sudden loss of vision.

Iris color change: what the label says

This is the side effect most people search for. The label (section 5.1) says latanoprost can increase the brown pigment of the iris. The change comes from more melanin inside existing pigment cells, not from more cells. In the 6-month trials, 7% of latanoprost patients had increased iris pigmentation.

  • It is slow. The change may not be noticeable for several months to years.
  • It typically starts as brown pigment around the pupil spreading outward, so the whole iris or parts of it become more brownish.
  • Freckles and nevi (spots) on the iris do not appear to be affected.
  • Pigmentation is expected to increase for as long as latanoprost is used, and after stopping, the iris change is likely to be permanent.
  • Beyond 5 years, the effects of increased pigmentation are not known.

The label's longer study followed 519 patients for 3 years with a 2-year extension (380 patients in the extension analysis). For most of those who developed noticeable darkening, it began within the first year, and pigmentation kept increasing through the 5 years. Darkening did not change the rate or severity of other adverse events, and pressure lowering was similar whether or not the iris darkened. The label says treatment can continue in people who develop it, with regular examinations.

The published report of that study (Alm and colleagues, Archives of Ophthalmology 2004) adds the timing. About 89% of the 380 patients in the extension had an eye colour known to be susceptible to change, yet after 5 years most patients had no increase in iris pigmentation. Among those whose irides did change, onset came within the first 8 months in 74% and within the first 24 months in 94%, and no patient developed new darkening after month 36. The authors note that certain iris colours were notably more susceptible than others. The study does not let you predict your own eyes, so ask your doctor to photograph them at the start.

If only one eye is treated, the colour difference between the eyes can become visible. Raise this with your doctor before you start if it would bother you.

Eyelash and eyelid changes

Latanoprost may gradually change eyelashes and fine (vellus) hair on the treated side: longer, thicker, darker, more numerous, and sometimes growing in the wrong direction. The label says lash changes are usually reversible after stopping. With one eye treated, lashes can look different between the eyes.

The eyelid skin can darken too. The label says this periorbital pigmentation has been reported to be reversible in some patients after stopping. Reports after approval also describe deepening of the eyelid sulcus.

The lash effect is the same prostaglandin effect behind bimatoprost lash serums. Latanoprost is not approved for lashes. If you are interested in lash growth, read our pages on Careprost vs Latisse and Lumigan vs Careprost, and do not add a bimatoprost serum on top of latanoprost without your eye doctor: the label says combined use of two or more prostaglandin analogs is not recommended.

Macular edema, inflammation and herpes keratitis

Three label warnings apply to specific groups:

  • Macular edema. Swelling at the centre of the retina, including cystoid macular edema, has been reported. Use with caution in people with no natural lens (aphakia), people with a lens implant and a torn posterior lens capsule, or anyone with known risk factors for macular edema. Tell your eye doctor if your vision becomes blurry or distorted, especially after cataract surgery.
  • Intraocular inflammation. Use with caution if you have a history of iritis or uveitis. The label says latanoprost should generally not be used during active intraocular inflammation because inflammation may get worse.
  • Herpes keratitis. Reactivation of herpes simplex keratitis has been reported. Use with caution if you have had it, and the label says to avoid latanoprost during active herpes simplex keratitis.

The label also warns about bacterial keratitis from multiple-dose bottles contaminated by patients, mostly in people who already had corneal disease. If you have eye surgery, an eye injury or an infection, or develop conjunctivitis or eyelid reactions, the label says to ask your doctor straight away whether to keep using the same bottle.

Who should not use latanoprost

The only contraindication on the Xalatan label is known hypersensitivity to latanoprost, benzalkonium chloride or any other ingredient. The Xelpros and Iyuzeh labels list hypersensitivity to latanoprost or any other ingredient, since they contain no BAK.

Beyond that, the warnings above mean your eye doctor needs to know if you have had uveitis or iritis, herpes eye infection, cataract surgery or another eye operation, or macular edema. Because asthma and angina appear in the post-approval reports, mention those too.

Latanoprost treats open-angle glaucoma and ocular hypertension. It is not a treatment for a sudden attack of angle-closure glaucoma, which is an emergency.

Pregnancy, breastfeeding and children

  • Pregnancy. There are no adequate and well-controlled studies in pregnant women. In animal studies, latanoprost given into a vein to pregnant rabbits and rats during organ formation caused malformations, embryofetal death and miscarriage at clinically relevant doses. Tell your doctor if you are pregnant or planning a pregnancy.
  • Breastfeeding. It is not known whether latanoprost or its metabolites pass into human milk, and the label advises caution.
  • Children. Safety and effectiveness in children have not been established.
  • Older adults. No overall differences in safety or effectiveness were seen between elderly and younger patients.

Xalatan vs generic latanoprost

Xalatan (application NDA 020597) was approved on 5 June 1996. Drugs@FDA lists the application holder as Upjohn, and the current US label is distributed by Viatris. The first FDA generics were approved on 22 March 2011, from five makers including Sandoz, Bausch and Lomb, Apotex and Somerset. Drugs@FDA (via openFDA) lists 12 approved generic (ANDA) applications for latanoprost eye drops in the dataset updated 28 October 2026: 7 marked prescription and 5 discontinued, plus one tentative approval.

The generic labels we read match Xalatan on strength (0.005%), preservative (BAK 0.02%), dose, warnings, the adverse reaction tables and storage. The listed inactive ingredients are the same buffer salts, sodium chloride and water, named slightly differently. If a switch between makers seems to cause more irritation, tell your doctor or pharmacist rather than stopping.

Xalatan comes as 2.5 mL of solution in a 5 mL clear bottle with a turquoise cap, per the label. Do not rely on cap colour alone to tell your drops apart; read the bottle.

Preservative-free and BAK-free latanoprost: Iyuzeh and Xelpros

BAK keeps multiple-dose bottles sterile but can irritate the eye surface, which matters for people using drops every day for decades or who already have dry eye. Two FDA-approved latanoprost products avoid BAK:

ProductFormPreservativeFDA approvalPressure lowering in its label
Xalatan and genericsSolution, 2.5 mL bottleBenzalkonium chloride 0.02%5 June 1996 (Xalatan)6 to 8 mmHg from 24 to 25 mmHg
Xelpros (Sun Pharma)Emulsion, 2.5 mL bottlePotassium sorbate 0.47% (no BAK)12 September 2018Up to 6 to 8 mmHg from 23 to 26 mmHg
Iyuzeh (Thea Pharma)Single-dose units, carton of 30None13 December 20223 to 8 mmHg vs 4 to 8 mmHg for preserved latanoprost, from 19 to 24 mmHg

Iyuzeh is the one with a direct comparison. In two trials against Xalatan, eye irritation was reported by 19% on Iyuzeh vs 31% on Xalatan, with other reactions at similar rates:

ReactionIyuzeh (n=378)Xalatan (n=358)
Conjunctival hyperemia34%37%
Eye irritation19%31%
Eye itching15%16%
Abnormal sensation in eye14%15%
Foreign body sensation12%10%
Blurred vision7%8%
Increased tearing5%4%
Light sensitivity3%5%
Grouped bar chart, Iyuzeh preservative-free latanoprost versus Xalatan preserved with benzalkonium chloride: conjunctival hyperemia 34% vs 37%, eye irritation 19% vs 31%, eye itching 15% vs 16%, abnormal sensation in eye 14% vs 15%, foreign body sensation 12% vs 10%, blurred vision 7% vs 8%, increased tearing 5% vs 4%, light sensitivity 3% vs 5%.
Figure 3. Eye reactions with preservative-free latanoprost (Iyuzeh) and preserved latanoprost (Xalatan) in the same two trials. Source: Iyuzeh US label, Table 1.

The trade-off is on the Iyuzeh label itself: preserved latanoprost was approximately 1 mmHg more effective than Iyuzeh. The redness rates here (34% and 37%) are much higher than the 8% in the older Xalatan trials. The labels themselves say adverse reaction rates from the clinical trials of one drug cannot be directly compared to rates in the trials of another, so compare only within each table.

Outside the label, a phase 3 US trial (Bacharach and colleagues, 2023) switched 335 patients whose pressure was already controlled on latanoprost to either a preservative-free latanoprost 0.005% formula (coded T2345) or BAK-preserved latanoprost for 84 days. Both kept pressure controlled; ocular treatment-emergent adverse events were reported by 13.9% vs 22.5%. A 2026 meta-analysis of 10 randomized trials with 1,880 patients (Alfatih and colleagues, Journal of Glaucoma) found no significant difference in pressure lowering at 4, 6 and 12 weeks, a small 0.43 mmHg edge for preserved drops at 2 weeks, and a lower risk of eye surface redness with preservative-free latanoprost (risk ratio 0.66). The authors rated the certainty of evidence low to moderate.

Xelpros has no comparator table in its label. Across its trials, eye pain or stinging on instillation was reported by 55% of 448 patients and ocular hyperemia by 41%. The openFDA copy of Drugs@FDA lists the Xelpros marketing status as discontinued in its 28 October 2026 update, although its DailyMed label was updated in December 2025; ask your pharmacist whether it is stocked.

Latanoprost vs bimatoprost and other prostaglandin drops

Latanoprost, bimatoprost (Lumigan) and travoprost belong to the same class. They share the once-daily evening dose, the iris and lash effects, and the rule against combining two of them. Our Lumigan eye drops guide covers bimatoprost 0.01% and 0.03% for glaucoma.

Two products with similar names are different drugs. Latanoprostene bunod (Vyzulta) is a separate molecule. Rocklatan (approved 12 March 2019) combines latanoprost 0.005% with netarsudil 0.02% in one bottle. Choosing between these is a decision for your eye doctor based on your pressure target and how your eyes tolerate each drop.

Using latanoprost with other glaucoma drops

Many people need more than one drug to reach their target pressure. The label allows latanoprost alongside other topical pressure-lowering drops, with at least 5 minutes between them. Common partners are from other classes: a beta blocker such as timolol, an alpha agonist such as brimonidine, or a carbonic anhydrase inhibitor such as dorzolamide. Fixed combinations such as dorzolamide with timolol or brimonidine with timolol can cut the number of bottles. What you should not add is a second prostaglandin, including travoprost and timolol combination drops such as Travacom, unless your doctor is replacing latanoprost with it.

What latanoprost costs

Cost has its own guide, buying eye drops from an online pharmacy, so this section is short. The federal NADAC survey reports what US retail pharmacies pay to buy a drug, not what patients pay at the counter. Latest values, week of 28 October 2026. The generic figure is the median across the generic NDC rows reported that week:

ProductNADAC per unitPer pack
Generic latanoprost 0.005%$1.57259 per mL$3.93 per 2.5 mL bottle
Xalatan 0.005%$108.34240 per mL$270.86 per 2.5 mL bottle
Iyuzeh 0.005%$10.11900 per single-dose unit$303.57 per carton of 30
Bar chart of NADAC US pharmacy acquisition cost per pack, week of 28 October 2026: generic latanoprost 2.5 mL bottle $3.93, Xalatan 2.5 mL bottle $270.86, Iyuzeh carton of 30 single-dose units $303.57.
Figure 4. What US retail pharmacies paid to buy each latanoprost product, per pack, in the latest NADAC week. Packs differ: Iyuzeh is sold as single-dose units. Source: CMS NADAC, as of 28 October 2026.

Xelpros had no NADAC entry in the 2026 data. Generic latanoprost costs US pharmacies a few dollars a bottle, while brand Xalatan and Iyuzeh cost them hundreds. Ask your US pharmacy or insurer what you would pay before buying elsewhere.

Buying latanoprost from outside the US

The FDA's personal importation page says: "In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S." It adds: "If a drug is approved for use in another country but is an unapproved new drug in the U.S. it is illegal to import." The page says FDA personnel "may consider a more permissive decision" in some situations, which it lists, and it states that "the FDA recommends only obtaining medicines from legal sources in the U.S." Indian latanoprost brands are not FDA-approved products, and generic latanoprost is widely available in US pharmacies. Read the FDA page in full and check your own situation and your country's rules before ordering.

Storage is the other issue. The US labels allow shipment at up to 40 °C for no more than 8 days. Our shipping page gives 7 to 14 business days for standard registered shipping to the USA and Canada, which is longer than that 8-day window even at the fast end. We could not read the Indian product labels themselves, but Indian pharmacy listings give refrigeration at 2 to 8 °C before opening for both brands we sell (Tata 1mg for Latoprost; Apollo Pharmacy and Truemeds for Lacoma PF). A parcel in transit is not refrigerated. If you live in the US, a local generic bottle avoids this problem. If you do order, follow the instructions on the carton you receive, refrigerate unopened bottles, use each bottle within 4 weeks of opening if the carton says so (the 1mg listing for Latoprost does; the Apollo Pharmacy listing for Lacoma PF gives 6 weeks at up to 25 °C), and discard any bottle that looks cloudy, discoloured or damaged.

For a checklist on judging any online seller of eye medicines, see how to buy eye care medicine online safely.

Latanoprost on SafeRxPills

We sell two Indian latanoprost brands. Prices from our catalogue as of 29 October 2026:

ProductMakerPackPricePer bottle
Latoprost Eye Drop (latanoprost 0.005%, 2.5 mL)Sun Pharmaceutical Industries1 bottle$24.00$24.00
3 bottles$56.00$18.67
6 bottles$100.00$16.67
Lacoma PF Eye Drop (latanoprost, 2.5 mL)Ajanta Pharma1 bottle$18.00$18.00
3 bottles$51.00$17.00
6 bottles$100.00$16.67

Lacoma PF is sold in India as "BAK free" in a 2.5 mL multi-dose bottle. We could not confirm from Ajanta's label whether it contains a different preservative, so do not assume it is preservative-free like Iyuzeh. We know of no published trial comparing it with Xalatan. Compare these prices with your US pharmacy price before ordering, as the NADAC figures above suggest generic latanoprost can be cheaper locally.

Questions to ask your eye doctor

  • What is my target eye pressure, and when will you check it after I start?
  • Should I treat one eye or both, and how will I notice iris or lash changes in one eye?
  • Would a preservative-free or BAK-free latanoprost suit me better if my eyes are dry or irritated?
  • Do I need a second drop, and in what order should I use them?
  • I have had cataract surgery, uveitis or herpes in the eye. Does that change anything?
  • How often should I have visual field and optic nerve checks?

Sources

  1. Xalatan (latanoprost ophthalmic solution) 0.005%, US prescribing information, Viatris Specialty, October 2024. DailyMed setid a98595b3-9f47-48e0-b18d-550a2095f264.
  2. Latanoprost ophthalmic solution 0.005%, US prescribing information, Sandoz, December 2024. DailyMed setid 1fba56a6-c8dc-4f34-b05d-efdea75d2fea.
  3. Latanoprost ophthalmic solution 0.005%, US prescribing information, Lifestar Pharma, September 2026. DailyMed setid 2c87e99e-33d4-4060-8876-ff05557c05eb.
  4. Iyuzeh (latanoprost ophthalmic solution) 0.005%, US prescribing information, Thea Pharma, July 2024. DailyMed setid 192fc081-cc38-4e83-b779-9592e060b915.
  5. Xelpros (latanoprost ophthalmic emulsion) 0.005%, US prescribing information, Sun Pharmaceutical Industries, December 2025. DailyMed setid 34ad5cf6-4df0-4104-bddd-4c7631133ded.
  6. US Food and Drug Administration. Drugs@FDA via openFDA: latanoprost applications NDA 020597, NDA 206185, NDA 216472, NDA 208259 and ANDAs, data updated 28 October 2026, accessed 29 October 2026.
  7. Garway-Heath DF, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 2015;385(9975):1295-304. PMID 25533656.
  8. Centers for Medicare and Medicaid Services. National Average Drug Acquisition Cost (NADAC), 2026 dataset, as of 28 October 2026.
  9. US Food and Drug Administration. Personal importation, accessed 29 October 2026.
  10. Alm et al. A 5-year, multicenter, open-label, safety study of adjunctive latanoprost therapy for glaucoma. Arch Ophthalmol 2004. PMID 15249358.
  11. Bacharach et al. Preservative-free versus benzalkonium chloride-preserved latanoprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension: a phase 3 US clinical trial. Clin Ophthalmol 2023. PMID 37674591.
  12. Alfatih et al. Efficacy and safety of preservative-free versus preserved latanoprost in glaucoma and ocular hypertension: a systematic review and meta-analysis. J Glaucoma 2026. PMID 41842582.
  13. Latanoprost 0.005% w/v eye drops solution, UK summary of product characteristics, Zentiva Pharma UK, electronic medicines compendium product 5974.

This guide is for information and does not replace advice from an eye doctor or pharmacist who knows your history. Glaucoma can cause permanent vision loss without symptoms. Do not stop or change glaucoma drops without medical advice, and seek emergency care for sudden eye pain, redness or loss of vision.

?Frequently Asked Questions

What is latanoprost used for?

Latanoprost 0.005% eye drops are approved to lower raised pressure inside the eye in people with open-angle glaucoma or ocular hypertension. Keeping pressure down slows further damage to the optic nerve; it does not reverse damage already done.

How do I use latanoprost eye drops?

Put one drop in the affected eye or eyes once daily in the evening. Remove contact lenses first and wait 15 minutes before putting them back, keep the bottle tip from touching anything, and leave at least 5 minutes between latanoprost and any other eye drop.

What are the most common latanoprost side effects?

In the trials behind the US label, the most common were foreign body sensation (13%), punctate keratitis (10%), stinging (9%), red eyes (8%), blurred vision (8%), itching (8%), burning (7%) and increased brown iris pigmentation (7%) over 6 months.

Does latanoprost change eye color permanently?

It can. The label says latanoprost can increase brown pigment in the iris, the change may take months to years to notice, it is expected to increase while you use the drug, and after stopping it is likely to be permanent. Eyelid darkening and lash changes are more often reversible.

Does latanoprost make eyelashes grow?

Yes, in the treated eye. The label says lashes and fine hair may become longer, thicker, darker and more numerous, and may grow in the wrong direction. These changes are usually reversible after stopping. Latanoprost is not approved as a lash treatment.

Does latanoprost need to be refrigerated?

Standard latanoprost solution does before opening: store unopened bottles at 2 to 8 °C (36 to 46 °F), protected from light. Once opened, the US labels allow room temperature up to 25 °C (77 °F) for 6 weeks, but the UK label and some Indian packs, such as Latoprost, say to use the bottle within 4 weeks of opening, so follow your own carton. Xelpros and Iyuzeh have different storage rules on their own labels.

Is generic latanoprost the same as Xalatan?

The US generic labels we read match Xalatan on strength (0.005%), preservative (benzalkonium chloride 0.02%), dose, warnings, side effect tables and storage. The first FDA generics were approved on 22 March 2011.

Is there a preservative-free latanoprost?

Yes. Iyuzeh, approved by the FDA in December 2022, comes in preservative-free single-dose units. In two trials against Xalatan, eye irritation was 19% vs 31%, but preserved latanoprost lowered pressure by about 1 mmHg more. Xelpros is an emulsion preserved with potassium sorbate instead of benzalkonium chloride.

What happens if I miss a dose of latanoprost?

The label says to continue with the next dose as normal. Do not use two drops or dose twice a day, because using prostaglandin drops more than once daily may weaken the pressure-lowering effect.

Can I use latanoprost with bimatoprost or a lash serum?

The label says combined use of two or more prostaglandins or prostaglandin analogs is not recommended. Bimatoprost, sold as Lumigan, Latisse and Careprost, is a prostaglandin analog, so ask your eye doctor before using it alongside latanoprost.

How quickly does latanoprost work?

Eye pressure starts to fall about 3 to 4 hours after a drop, reaches its maximum effect at 8 to 12 hours and stays lower for at least 24 hours. In the label trials, pressure fell by 6 to 8 mmHg from 24 to 25 mmHg over 6 months.

S

SafeRxPills Pharmacy Team

Pharmacist, Content, B.Pharm, M.Pharm, Rajiv Gandhi University

Pharmacist writing on antiparasitic, ophthalmic and dermatological generics. Focuses on what the regulatory labelling and published evidence actually support.

Comments (0)

Leave a Comment

No comments yet. Be the first to share your thoughts!